In the BioHarmony Drug Report Database
Dienogest
Natazia (dienogest) is a small molecule pharmaceutical. Dienogest was first approved as Natazia on 2010-05-06. It is used to treat endometriosis in the USA. Natazia’s patents are valid until 2028-01-30 (FDA).
Trade Name
|
Natazia |
|---|---|
Common Name
|
dienogest |
ChEMBL ID
|
CHEMBL1201864 |
Indication
|
endometriosis |
Drug Class
|
Progestogen; Progestin; Steroidal antiandrogen |
Image (chem structure or protein)